Peter Gottle
Duesseldorf, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Multiple sclerosis drug repurposing for neuroregeneration.
Journal: Neural regeneration research
Published: September 18, 2023
A Novel Ex Vivo Model to Study Therapeutic Treatments for Myelin Repair following Ischemic Damage.
Journal: International journal of molecular sciences
Published: May 31, 2023
Siponimod Modulates the Reaction of Microglial Cells to Pro-Inflammatory Stimulation.
Journal: International journal of molecular sciences
Published: September 23, 2022
Teriflunomide as a therapeutic means for myelin repair.
Journal: Journal of neuroinflammation
Published: September 16, 2022
There is more than one route to achieve myelin repair.
Journal: Regenerative medicine
Published: July 11, 2022
Increased Remyelination and Proregenerative Microglia Under Siponimod Therapy in Mechanistic Models.
Increased Remyelination and Proregenerative Microglia Under Siponimod Therapy in Mechanistic Models.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: September 20, 2021
TLR4 Associated Signaling Disrupters as a New Means to Overcome HERV-W Envelope-Mediated Myelination Deficits.
Journal: Frontiers in cellular neuroscience
Published: September 15, 2021
Microglia contributes to remyelination in cerebral but not spinal cord ischemia.
Journal: Glia
Published: May 07, 2021
C21orf91 Regulates Oligodendroglial Precursor Cell Fate-A Switch in the Glial Lineage?
Journal: Frontiers in cellular neuroscience
Published: January 13, 2021
Meeting report: "Human endogenous retroviruses: HERVs or transposable elements in autoimmune, chronic inflammatory and degenerative diseases or cancer", Lyon, France, november 5th and 6th 2019 - an MS scientist's digest.
Journal: Multiple sclerosis and related disorders
Published: February 18, 2020
Last Updated: 09/26/2026